Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3).

Isaacs, Claudine; O'Regan, Ruth; Andre, Fabrice; Toi, Masakazu; Jerusalem, Guy Heinrich Maria; Wilks, Sharon; Xu, Binghe; Masuda, Norikazu; Arena, Francis P.; Yardley, Denise Aysel; Yap, Yoon Sim; Mukhopadhyay, Pabak; Douma, Shyanne; El-Hashimy, Mona; Taran, Tanya; Sahmoud, Tarek; Lebwohl, David Edward; Gianni, Luca; Ozguroglu, Mustafa

dc.contributor.author	Isaacs, Claudine
dc.contributor.author	O'Regan, Ruth
dc.contributor.author	Andre, Fabrice
dc.contributor.author	Toi, Masakazu
dc.contributor.author	Jerusalem, Guy Heinrich Maria
dc.contributor.author	Wilks, Sharon
dc.contributor.author	Xu, Binghe
dc.contributor.author	Masuda, Norikazu
dc.contributor.author	Arena, Francis P.
dc.contributor.author	Yardley, Denise Aysel
dc.contributor.author	Yap, Yoon Sim
dc.contributor.author	Mukhopadhyay, Pabak
dc.contributor.author	Douma, Shyanne
dc.contributor.author	El-Hashimy, Mona
dc.contributor.author	Taran, Tanya
dc.contributor.author	Sahmoud, Tarek
dc.contributor.author	Lebwohl, David Edward
dc.contributor.author	Gianni, Luca
dc.contributor.author	Ozguroglu, Mustafa
dc.date.accessioned	2021-03-06T10:38:32Z
dc.date.available	2021-03-06T10:38:32Z
dc.identifier.citation	O'Regan R., Ozguroglu M., Andre F., Toi M., Jerusalem G. H. M. , Wilks S., Isaacs C., Xu B., Masuda N., Arena F. P. , et al., "Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3).", 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31
dc.identifier.other	av_eb53b5e5-bcfc-4399-8bd3-6ece49afd8c8
dc.identifier.other	vv_1032021
dc.identifier.uri	http://hdl.handle.net/20.500.12627/154552
dc.language.iso	eng
dc.subject	İç Hastalıkları
dc.subject	ONKOLOJİ
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	Onkoloji
dc.title	Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3).
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	31
dc.contributor.firstauthorID	141659

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster